No. |
DrugBank |
薬物名(臨床試験情報から抽出) |
KEGG DRUG * | KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 | Desmopressin | 7件: Ddavp (desmopressin); Desmopressin; Desmopressin acetat; Desmopressin acetate; Desmopressin acetate trihydrate; Desmopressin intranasal; Desmopressin oral melt; | D00291 D02235 |
2件: AVPR2, F8 |
4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
6件: 6, 64, 72, 75, 225, 288 |
2 | Empagliflozin | 3件: Empagliflozin; Empagliflozin 25mg; Empagliflozin 25mg tbl; | D10459 |
- |
- |
2件: 72, 257 |
3 | Satavaptan | 2件: Satavaptan; Satavaptan (sr121463b); | - |
- |
- |
1件: 72 |
4 | Tolvaptan | 15件: Jinarc - tolvaptan tablets; Opc-41061 (tolvaptan); Tolvaptan; Tolvaptan (opc-41061); Tolvaptan 15 mg tablet; Tolvaptan 15 mg tablets; Tolvaptan 15mg; Tolvaptan 30 mg tablet; Tolvaptan 30 mg tablets; Tolvaptan 30mg; Tolvaptan 7.5 mg tablet; Tolvaptan in euvolemic hyponatremia; Tolvaptan ir; Tolvaptan mr; Tolvaptan oral tablet; | D01213 |
1件: AVPR2 |
3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption |
3件: 67, 72, 225 |